The Science

Meibomian gland dysfunction isn't chronic. It's undertreated.

The research on warm compress therapy is unambiguous. The problem has always been delivery — hitting 40–45°C at the eyelid surface, consistently, for long enough to work.

CE-marked Class I Medical Device Ophthalmologist-designed Made in Latvia, EU Free EU shipping
CE-marked
Class I Medical Device
EU MDR Compliant
Ophthalmologist-
Developed
Made in Latvia, EU
Free EU Shipping
+ 14-Day Returns
Phthalate-Free

The Biology

The Tear Film Has Three Layers. Only One Protects It.

The meibomian glands produce the lipid layer that prevents tear film evaporation.

When glands become blocked, the oil hardens and stops flowing — the tear film collapses.

Blocked meibum has a melting point of 32–35°C in healthy glands. In dysfunctional glands: 40–45°C.

Standard warm compresses cool to below therapeutic temperature within 2 minutes.

The outermost layer of your tear film is a nanometre-thin sheet of oil secreted by meibomian glands in your eyelids. It is the only barrier preventing your tears from evaporating between blinks. When those glands become blocked — by age, screen exposure, or contact lens use — the lipid layer degrades, the tear film collapses, and every symptom of dry eye follows. This is meibomian gland dysfunction, and it accounts for the majority of chronic dry eye cases.

Screen Time Impact Calculator

Severe

Impact level

81%
Low
Severe

Annual Screen Hours

4,745

Strain Index

Severe

By spending 13 hours on a monitor daily, you miss approximately 43,680 blinks every week. High risk of chronic dry eye and tension headaches.

Hours per Day 13h

Screen Type

Regular Breaks?

The Clinical Parameters

What the Research Actually Specifies

For Professionals

Temperature Threshold

Clinical studies establish 40–45°C as the minimum eyelid surface temperature needed to liquefy hardened meibum in dysfunctional glands.

For Professionals

Duration Requirement

10 minutes of sustained heat is the minimum treatment duration supported by clinical evidence for measurable gland clearing.

For Professionals

Contact Surface

Effective therapy requires contact across the full tarsus — the gland-bearing section of the eyelid — not just the central zone.

For Professionals

Frequency

Daily use is the evidence-supported protocol. MGD is chronic. Intermittent treatment produces intermittent results.

How RevivifEye Applies It

Built to Meet Every Clinical Requirement

1

Confirmed Temperature

The thermal indicator on the mask surface confirms the correct therapeutic range before and during use. No guessing. No cooling below threshold unnoticed.

2

Full Tarsus Contact

Shaped to the anatomy of the human eyelid. Even heat from inner to outer canthus — the full meibomian gland line, not just the area above the pupil.

3

Sustained 10-Minute Delivery

The gel formulation retains therapeutic heat for the full treatment duration — consistent across the session, not declining from the first minute.

Temperature. Duration. Coverage. The three variables the research specifies — all solved.

What Clinicians and Patients Say

Dr. T.V., Optometrist Verified Buyer

Recommending it to patients

The temperature indicator addresses the most common reason warm compress therapy fails — patient uncertainty about whether it's working. I've started recommending RevivifEye specifically.

RevivifEye Care

Lena S., Helsinki Verified Buyer

Actually maintained the heat

I tried rice bags and other compresses for months. They all cooled down in minutes. RevivifEye was still warm at the end of the 10 minutes. That's the whole point.

RevivifEye Care

James O., Dublin Verified Buyer

Knowing it's working makes all the difference

The indicator changing colour when it hits temperature — that one feature changed everything for me. I knew with rice bags I was probably wasting my time.

RevivifEye Care

The Specifications

Four Clinical Requirements. All Met.

40–45°C Confirmed

Thermal indicator surface-verifies the clinical temperature range before and during treatment.

10-Minute Retention

Gel formulation sustains therapeutic heat for the full evidence-supported treatment duration.

Full Tarsus Coverage

Anatomical design contacts the complete gland line — upper and lower lids, inner to outer canthus.

Evidence-Based Design

Every specification traces back to a published clinical parameter. Nothing added, nothing omitted.

The science has always been sound. The tools are ready now.

Warm compress therapy that meets the clinical specification.

RevivifEye Care and Focus deliver the temperature, duration, and eyelid coverage the evidence specifies — in a device designed by the clinicians who wrote those specifications.

Shop RevivifEye

Free EU shipping · 14-day returns · CE-marked Class I Medical Device